Increased crystallization of the product was found in the concentrate for solution for injection or infusion, which may affect the safety and efficacy of intravenous administration. Potential effects: vascular embolism, lack of treatment efficacy, intravenous complications.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use product from batch 139503A, check the batch number and return the product to the pharmacy; if the product has been used, contact a doctor.
Withdrawal from the market throughout the entire country of batch 139503A of the medicinal product Amiodaron Hameln, with the decision given immediate enforceability.
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related